Obagi Medical Products, Inc. (OMPI) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 367 transactions totaling $182.6M, demonstrating a bearish sentiment with -$182.6M in net insider flow. The most recent transaction on Apr 25, 2013 involved a transaction of 65,787 shares valued at $1.6M.
No significant insider buying has been recorded for OMPI in the recent period.
No significant insider selling has been recorded for OMPI in the recent period.
Based on recent SEC filings, insider sentiment for OMPI is bearish with an Insider Alignment Score of 0/100 and a net flow of -$182.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Obagi Medical Products, Inc. (OMPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading OMPI stock, having executed 367 transactions in the past 90 days. The most active insider is Partners Inc Stonington II (Executive), who has made 1 transactions totaling $84.0M.
Get notified when executives and directors at OMPI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 25, 2013 | F. Hummel Albert | Executive | Disposition | 65,787 | $24.00 | $1.6M | Large |
| Apr 25, 2013 | Thomas Taylor Mark | Executive | Disposition | 12,294 | $24.00 | $295.1K | |
| Apr 25, 2013 | P. Badie Ronald | Executive | Disposition | 16,746 | $24.00 | $401.9K | |
| Apr 25, 2013 | P. Badie Ronald | Executive | Disposition | 2,206 | $24.00 | $52.9K | |
| Apr 25, 2013 | A. Bartholdson John | Executive | Disposition | 2,206 | $24.00 | $52.9K | |
| Apr 25, 2013 | A. Bartholdson John | Executive | Disposition | 15,747 | $24.00 | $377.9K | |
| Apr 25, 2013 | H. Duerden John | Executive | Disposition | 13,220 | $24.00 | $317.3K | |
| Apr 25, 2013 | H. Duerden John | Executive | Disposition | 2,206 | $24.00 | $52.9K | |
| Apr 25, 2013 | J. Fitzgibbons Albert III | Executive | Disposition | 2,206 | $24.00 | $52.9K | |
| Apr 25, 2013 | J. Fitzgibbons Albert III | Executive | Disposition | 15,747 | $24.00 | $377.9K | |
| Apr 25, 2013 | A. Grant Edward | Executive | Disposition | 18,996 | $24.00 | $455.9K | |
| Apr 25, 2013 | A. Grant Edward | Executive | Disposition | 2,206 | $24.00 | $52.9K | |
| Apr 25, 2013 | M. Leslie Kristina | Executive | Disposition | 4,890 | $24.00 | $117.4K | |
| Sep 11, 2012 | S. Romm Preston | Executive | Sale | 63,763 | $13.20 | $841.7K | Large |
| Sep 11, 2012 | S. Romm Preston | Executive | Sale | 1,900 | $13.02 | $24.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 294 | $182.6M | 75.5% |
Disposition(D) | 15 | $57.1M | 23.6% |
Exercise(M) | 13 | $1.8M | 0.8% |
Award(A) | 43 | $140.4K | 0.1% |
Purchase(P) | 2 | $9.9K | 0.0% |
Insider selling pressure at Obagi Medical Products, Inc. has increased, with 17 insiders executing 367 transactions across all time. Total sales of $182.6M significantly outpace purchases of $9.9K, resulting in a net outflow of $182.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.